Product Images Lisdexamfetamine Dimesylate
View Photos of Packaging, Labels & Appearance
- Lisdexamfetamine Dimesylate Structural Formula - image 01
- Figure 1: Specific Populations* - image 02
- Figure 2: Effect of Other Drugs on Lisdexamfetamine Dimesylate - image 03
- Figure 3: Effect of Lisdexamfetamine Dimesylate on Other Drugs - image 04
- Figure 4: LS Mean SKAMP Deportment Subscale Score by Treatment and Time-point for Children Ages 6 to 12 with ADHD After 1 Week of Double-Blind Treatment (Study 3) - image 05
- Figure 5: Kaplan-Meier Estimated Proportion of Patients with Treatment Failure for Pediatric Patients Ages 6 to 17 (Study 6) - image 06
- Figure 6: LS Mean (SE) PERMP Total Score by Treatment and Time-point for Adults Ages 18 to 55 with ADHD after 1 Week of Double-Blind Treatment (Study 8) - image 07
- Figure 7: Kaplan-Meier Estimated Proportion of Subjects with Relapse in Adults with ADHD (Study 9) - image 08
- Figure 8: Kaplan-Meier Estimated Proportion of Subjects with Relapse in Adults with BED (Study 13) - image 09
- Lisdexamfetamine Dimesylate Capsules 10 mg Bottle Label - image 10
- Lisdexamfetamine Dimesylate Capsules 20 mg Bottle Label - image 11
- Lisdexamfetamine Dimesylate Capsules 30 mg Bottle Label - image 12
- Lisdexamfetamine Dimesylate Capsules 40 mg Bottle Label - image 13
- Lisdexamfetamine Dimesylate Capsules 50 mg Bottle Label - image 14
- Lisdexamfetamine Dimesylate Capsules 60 mg Bottle Label - image 15
- Lisdexamfetamine Dimesylate Capsules 70 mg Bottle Label - image 16
Product Label Images
The following 16 images provide visual information about the product associated with Lisdexamfetamine Dimesylate NDC 0378-6860 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Lisdexamfetamine Dimesylate Structural Formula - image 01
Figure 1: Specific Populations* - image 02
Figure 2: Effect of Other Drugs on Lisdexamfetamine Dimesylate - image 03
Figure 3: Effect of Lisdexamfetamine Dimesylate on Other Drugs - image 04
Figure 4: LS Mean SKAMP Deportment Subscale Score by Treatment and Time-point for Children Ages 6 to 12 with ADHD After 1 Week of Double-Blind Treatment (Study 3) - image 05
Figure 5: Kaplan-Meier Estimated Proportion of Patients with Treatment Failure for Pediatric Patients Ages 6 to 17 (Study 6) - image 06
Figure 6: LS Mean (SE) PERMP Total Score by Treatment and Time-point for Adults Ages 18 to 55 with ADHD after 1 Week of Double-Blind Treatment (Study 8) - image 07
Figure 7: Kaplan-Meier Estimated Proportion of Subjects with Relapse in Adults with ADHD (Study 9) - image 08
Figure 8: Kaplan-Meier Estimated Proportion of Subjects with Relapse in Adults with BED (Study 13) - image 09
Lisdexamfetamine Dimesylate Capsules 10 mg Bottle Label - image 10
Lisdexamfetamine Dimesylate Capsules 20 mg Bottle Label - image 11
Lisdexamfetamine Dimesylate Capsules 30 mg Bottle Label - image 12
Lisdexamfetamine Dimesylate Capsules 40 mg Bottle Label - image 13
Lisdexamfetamine Dimesylate Capsules 50 mg Bottle Label - image 14
Lisdexamfetamine Dimesylate Capsules 60 mg Bottle Label - image 15
Lisdexamfetamine Dimesylate Capsules 70 mg Bottle Label - image 16
